NCT00004787
- Conditions
- Anemia, Anemia, Aplastic, Anemia, Hypoplastic, Congenital, +34 more
- Locations
-
Not specified
Clinical trial condition
Pancreatic Diseases
Explore clinical trials studying Pancreatic Diseases. Study availability and eligibility vary by location and protocol.
4,381 public trials
841 recruiting studies
Pancreatic Diseases trial results
NCT00004779
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +9 more
- Locations
-
Not specified
NCT00004747
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Communicable Diseases, +14 more
- Locations
-
Not specified
NCT00004296
- Conditions
- Actinomycetales Infections, Atypical Mycobacterium Infection, Bacterial Infections, +19 more
- Locations
-
Not specified
NCT00041808
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +49 more
- Locations
-
- Scripps Stevens Cancer Division San Diego, California, United States
- UCSF Cancer Center San Francisco, California, United States
- Scott and White Clinic Temple, Texas, United States
- Frankfurt Universtiy Frankfurt, Germany
NCT00006063
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +9 more
- Locations
-
Not specified
NCT00008762
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
- Locations
-
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
Completed
Phase I Study of the Third Generation Adenovirus H5.001CBCFTR in Patients With Cystic Fibrosis
NCT00004287
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +9 more
- Locations
-
Not specified
NCT00005112
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
- Locations
-
- University of Texas Medical School Houston, Texas, United States
- University of Utah, Dept of Pediatric Endocrinology Salt Lake City, Utah, United States
Active, Not Recruiting
Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors
NCT04616534
- Conditions
- Adnexal Diseases, Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Neoplasm, +40 more
- Locations
-
- National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States